| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |